Drug-Induced Hypertension: Focus on Mechanisms and Management.

Abstract:

PURPOSE OF REVIEW:This review is intended to briefly describe the primary mechanistic pathways by which several common drugs can increase blood pressure. We also propose potential management strategies based on the underlying mechanisms responsible for the blood pressure elevation. RECENT FINDINGS:As hypertension is a significant risk factor for cardiovascular events, healthcare providers must evaluate patients' concomitant medications that may contribute to elevations in blood pressure. The presence of these medications, if not properly addressed, can lead to consequences such as an inadvertent diagnosis of hypertension, as well as the potential need for unnecessary intensification of antihypertensive regimens in those already treated. Blood pressure elevation is an unfortunate by-product of multiple medications. The substances discussed in this review can elicit significant and persistent elevations in blood pressure, and health care providers must first evaluate whether the drug is necessary. If one exists, it is best to select a similar agent with lower risk of increasing blood pressure; if unavoidable, then clinicians should select an appropriate management strategy to compensate for the rise in blood pressure.

journal_name

Curr Hypertens Rep

authors

Lovell AR,Ernst ME

doi

10.1007/s11906-017-0736-z

subject

Has Abstract

pub_date

2017-05-01 00:00:00

pages

39

issue

5

eissn

1522-6417

issn

1534-3111

pii

10.1007/s11906-017-0736-z

journal_volume

19

pub_type

杂志文章,评审
  • Activation of mineralocorticoid receptor in salt-sensitive hypertension.

    abstract::The impaired capacity of the kidney to excrete sodium plays an essential role in the development of hypertension. Adrenal corticosteroids control renal handling of sodium by regulating tubular sodium reabsorption in the distal nephron where both mineralocorticoid receptors (MR) and glucocorticoid receptors are express...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-015-0552-2

    authors: Ayuzawa N,Fujita T

    更新日期:2015-06-01 00:00:00

  • Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla.

    abstract::The central nervous system plays a key role in the regulation of cardiovascular function, and alterations in the central neural mechanisms that control blood pressure may underlie the vast majority of cases of primary hypertension. The well-studied baroreceptor reflex powerfully regulates arterial pressure, though its...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-003-0030-0

    authors: Sved AF,Ito S,Sved JC

    更新日期:2003-06-01 00:00:00

  • Hypertension in multicultural and minority populations: linking communication to compliance.

    abstract::Cardiovascular disease disproportionately affects minority populations, in part because of multiple sociocultural factors that directly affect compliance with antihypertensive medication regimens. Compliance is a complex health behavior determined by a variety of socioeconomic, individual, familial, and cultural facto...

    journal_title:Current hypertension reports

    pub_type: 杂志文章

    doi:10.1007/BF03215777

    authors: Betancourt JR,Carrillo JE,Green AR

    更新日期:1999-12-01 00:00:00

  • Diastolic pressure, systolic pressure, or pulse pressure?

    abstract::Diastolic pressure, systolic pressure, and pulse pressure have all been assigned the role of the best predictor of cardiovascular events during the 20th century. At the dawn of the new millennium, concepts that draw attention to vascular mechanics reconcile the seemingly conflicting results of epidemiologic studies, b...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-000-0010-6

    authors: Vlachopoulos C,O'Rourke M

    更新日期:2000-06-01 00:00:00

  • Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection.

    abstract:PURPOSE OF REVIEW:In chronic kidney disease (CKD), plasma uric acid levels are increased because of the decrease in glomerular filtration rate. However, in addition to CKD, hyperuricemia is frequently associated with a number of other conditions such as hypertension, type 2 diabetes, obesity, and heart failure, overwei...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-020-01116-3

    authors: Kielstein JT,Pontremoli R,Burnier M

    更新日期:2020-10-31 00:00:00

  • Resistant hypertension and the Birmingham Hypertension Square.

    abstract::Recent guidelines for the treatment of hypertension place great emphasis on tighter blood pressure control, especially in the presence of hypertensive target organ damage and diabetes. In order to achieve these treatment targets, more patients will require a combination of antihypertensive medications. However, resist...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-001-0039-1

    authors: Felmeden DC,Lip GY

    更新日期:2001-06-01 00:00:00

  • Intrarenal Angiotensin-Converting Enzyme: the Old and the New.

    abstract:PURPOSE OF REVIEW:The intrarenal renin-angiotensin-aldosterone system (RAS) is an independent paracrine hormonal system with an increasingly prominent role in hypertension and renal disease. Two enzyme components of this system are angiotensin-converting enzyme (ACE) and more recently discovered ACE2. The purpose of th...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-017-0778-2

    authors: Culver S,Li C,Siragy HM

    更新日期:2017-09-19 00:00:00

  • Investigating Maternal Brain Alterations in Preeclampsia: the Need for a Multidisciplinary Effort.

    abstract:PURPOSE OF REVIEW:To provide insight into the mechanisms underlying cerebral pathophysiology and to highlight possible methods for evaluation, screening, and surveillance of cerebral complications in preeclampsia. RECENT FINDINGS:The pathophysiology of eclampsia remains enigmatic. Animal studies show that the cerebral...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-019-0977-0

    authors: Bergman L,Torres-Vergara P,Penny J,Wikström J,Nelander M,Leon J,Tolcher M,Roberts JM,Wikström AK,Escudero C

    更新日期:2019-08-02 00:00:00

  • Organ selective regulation of sympathetic outflow by the brain Angiotensin system.

    abstract::Angiotensin II (Ang II) has actions on the sympathetic nervous system both as a circulating hormone acting on the circumventricular organs and also as a neurotransmitter/ neuromodulator acting within the brain. Administration of Ang II into the cerebral ventricles has diverse effects on sympathetic nerve activity (SNA...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-013-0355-2

    authors: Ramchandra R,Yao ST,May CN

    更新日期:2013-08-01 00:00:00

  • Renin inhibitors: optimal strategy for renal protection.

    abstract::Diabetic nephropathy and hypertension are the major causes of chronic kidney disease. The renin system plays a key role in the control of blood pressure (BP), as well as in the regulation of renal and adrenal function. Chronic activation of the renin system can lead to organ damage, particularly renal damage; increasi...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-007-0076-5

    authors: Schmieder RE

    更新日期:2007-11-01 00:00:00

  • AT(2) receptor and tissue injury: therapeutic implications.

    abstract::The renin-angiotensin system (RAS) plays an important role in the initiation and progression of tissue injuries in the cardiovascular and nervous systems. The detrimental actions of the AT1 receptor (AT1R) in hypertension and vascular injury, myocardial infarction and brain ischemia are well established. In the past t...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-013-0416-6

    authors: Namsolleck P,Recarti C,Foulquier S,Steckelings UM,Unger T

    更新日期:2014-02-01 00:00:00

  • Effects of Probiotics on Patients with Hypertension: a Systematic Review and Meta-Analysis.

    abstract:PURPOSE OF REVIEW:This meta-analysis and systematic review was conducted to evaluate the effect of probiotics on blood pressure, body mass index (BMI), and blood glucose changes in patients with hypertension. RECENT FINDINGS:We searched the PubMed, Cochrane, Embase, and ProQuest databases using a combination of MeSH a...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,meta分析

    doi:10.1007/s11906-020-01042-4

    authors: Chi C,Li C,Wu D,Buys N,Wang W,Fan H,Sun J

    更新日期:2020-03-21 00:00:00

  • Glutathione-S-transferase M1 and T1 null genotypes are associated with hypertension risk: a systematic review and meta-analysis of 12 studies.

    abstract::Oxidative stress is known to be implicated in the pathogenesis of essential hypertension. Glutathione-S-transferase (GST) enzymes are key components of cellular defense against oxidative stress. The present study aimed to clarify the association between polymorphisms in GST and risk of essential hypertension using a m...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,meta分析,评审

    doi:10.1007/s11906-014-0432-1

    authors: Eslami S,Sahebkar A

    更新日期:2014-06-01 00:00:00

  • Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension.

    abstract:PURPOSE OF REVIEW:Here, we review the known relations between hypertension and obesity to inflammation and postulate the endogenous protective effect of melatonin and its potential as a therapeutic agent. We will describe the multiple effects of melatonin on blood pressure, adiposity, body weight, and focus on mitochon...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-018-0842-6

    authors: Prado NJ,Ferder L,Manucha W,Diez ER

    更新日期:2018-05-09 00:00:00

  • Biomarkers in hypertension and their relationship with myocardial target-organ damage.

    abstract::Essential hypertension is a very common health condition that is associated with an array of long-term end-organ diseases, including premature cardiovascular disease. Currently, there is no effective method to identify high-risk patients who may develop cardiovascular comorbidities in the future. Clinically, it would ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-014-0502-4

    authors: Xue Y,Iqbal N,Chan J,Maisel A

    更新日期:2014-12-01 00:00:00

  • Endogenous ouabain: a link between sodium intake and hypertension.

    abstract::The sodium pump, an ancestral enzyme with conserved ability to bind ouabain, plays a key role in salt conservation and is regulated by aldosterone and endogenous ouabain (EO). Plasma EO is elevated in about 45% of patients with essential hypertension and correlates with blood pressure. The relationship of EO with Na(+...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-010-0161-z

    authors: Hamlyn JM,Manunta P

    更新日期:2011-02-01 00:00:00

  • Cognitive function in hypertensive children.

    abstract::Young hypertensive adults demonstrate decreased performance on neurocognitive testing compared with that of normotensive controls. There is emerging, preliminary evidence that children with hypertension also manifest cognitive differences when compared to normotensive controls. These preliminary studies consist mostly...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-014-0508-y

    authors: Lande MB,Kupferman JC

    更新日期:2015-01-01 00:00:00

  • Regulation of sodium/potassium ATPase activity: impact on salt balance and vascular contractility.

    abstract::Na+,K+-ATPase distributes ions between the intracellular and extracellular space and is responsible for total-body sodium homeostasis. The activity of this ion pump is regulated by catecholamines and peptide hormones; by the ligand of Na+,K+-ATPase, ouabain; and by direct interaction with cytoskeleton proteins. This r...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-001-0032-8

    authors: Aperia A

    更新日期:2001-04-01 00:00:00

  • Opportunities to Leverage Telehealth Approaches Along the Hypertension Control Cascade in Sub-Saharan Africa.

    abstract:PURPOSE OF REVIEW:To review the current literature on use of telehealth at different stages of the hypertension control cascade in sub-Saharan Africa (SSA) and to discuss opportunities to harness technology infrastructure in SSA to improve population-level blood pressure control. RECENT FINDINGS:Despite the high burde...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-019-0983-2

    authors: Muiruri C,Manavalan P,Jazowski SA,Knettel BA,Vilme H,Zullig LL

    更新日期:2019-08-26 00:00:00

  • Seek and destroy: the ubiquitin----proteasome system in cardiac disease.

    abstract::The ubiquitin-proteasome system (UPS) is a major proteolytic system that regulates the degradation of intracellular proteins in the heart. The UPS regulates the turnover of misfolded and damaged proteins, in addition to numerous cellular processes, by affecting the stability of short-lived proteins such as transcripti...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-009-0069-7

    authors: Rodríguez JE,Schisler JC,Patterson C,Willis MS

    更新日期:2009-12-01 00:00:00

  • Invasive treatment of resistant hypertension: present and future.

    abstract::The underlying pathophysiologic concept of diverse invasive devices to treat resistant hypertension (e.g., sympathetic denervation, carotid sinus nerve stimulation) is known for a long time. Since the pioneering work in the 1940s in humans, innovative techniques have been developed resulting in less invasive treatment...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-014-0488-y

    authors: Ott C,Schmieder RE

    更新日期:2014-11-01 00:00:00

  • Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials.

    abstract:PURPOSE OF REVIEW:There is an established association between hypertension and increased risk of poor cognitive performance and dementia including Alzheimer's disease; however, associations between antihypertensive medications (AHMs) and dementia risk are less consistent. An increased interest in AHM has resulted in ex...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-016-0674-1

    authors: Yasar S,Schuchman M,Peters J,Anstey KJ,Carlson MC,Peters R

    更新日期:2016-08-01 00:00:00

  • New-onset diabetes in treated hypertensive patients.

    abstract::Interpretation of some recent trials in hypertension opened a debate on the clinical value of new-onset diabetes in treated hypertensive patients. It is not completely clear whether certain antihypertensive drug classes are associated with a higher risk for developing type 2 diabetes when compared with other classes. ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-005-0006-3

    authors: Verdecchia P,Angeli F,Reboldi GP,Gattobigio R

    更新日期:2005-06-01 00:00:00

  • Blood pressure variability, cardiovascular risk, and risk for renal disease progression.

    abstract::The adverse cardiovascular consequences of high blood pressure (BP) not only depend on absolute BP values, but also on BP variability (BPV). Evidence has been provided that independently of mean BP levels, BP variations in the short- and long-term are associated with the development, progression and severity of cardia...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-012-0290-7

    authors: Parati G,Ochoa JE,Bilo G

    更新日期:2012-10-01 00:00:00

  • Nonesterified fatty acids in blood pressure control and cardiovascular complications.

    abstract::The fact that cardiovascular risk factors cluster among individuals with the insulin resistance syndrome strongly suggests a common pathogenetic denominator. For many years, abnormalities of nonesterified fatty acid metabolism have been implicated in the disturbances of carbohydrate and lipid metabolism that character...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-001-0021-y

    authors: Egan BM,Greene EL,Goodfriend TL

    更新日期:2001-04-01 00:00:00

  • Prevalence and diagnosis of primary aldosteronism.

    abstract::Primary aldosteronism (PA) is a common cause of arterial hypertension: in the PA Prevalence in Hypertensives (PAPY) Study, the prevalence of PA was 11.2% in consecutive referred hypertensive patients. When adrenal vein sampling (AVS) is available, two thirds of the cases can be attributed to a tumor and one third of c...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-010-0134-2

    authors: Rossi GP

    更新日期:2010-10-01 00:00:00

  • Albuminuria: what can we expect from the determination of nonimmunoreactive albumin?

    abstract::Albuminuria is an early marker for diabetic nephropathy in patients with diabetes, and has a clear place in patient care. It also predicts cardiovascular events and mortality in diabetic patients and in the general population, and is slowly becoming accepted in population screening for cardiovascular disease and chron...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-009-0021-x

    authors: Bakker SJ,Gansevoort RT,de Zeeuw D

    更新日期:2009-04-01 00:00:00

  • Angiotensinogen variants and human hypertension.

    abstract::The research on molecular genetics of human hypertension aims to identify the loci involved in the regulation of blood pressure, detect gene variants within the identified loci, associate them with intermediate phenotypes, and ultimately estimate their quantitative effects on blood pressure level and their interaction...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-999-0071-0

    authors: Jeunemaitre X,Gimenez-Roqueplo AP,Célérier J,Corvol P

    更新日期:1999-02-01 00:00:00

  • Ongoing trials: what should we expect after ALLHAT?

    abstract::The publication of the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT) results, when used in conjunction with a new meta-analysis, provides hypertension research with a watershed. Data demonstrate clearly that lowering blood pressure is the most important aspect of hypertension man...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,meta分析

    doi:10.1007/s11906-003-0044-7

    authors: Wang JG,Staessen JA,Heagerty AM

    更新日期:2003-08-01 00:00:00

  • Angiotensin-converting enzyme 2: possible role in hypertension and kidney disease.

    abstract::The discovery of angiotensin-converting enzyme (ACE) 2 adds a new level of complexity to the understanding of the renin-angiotensin system. The high catalytic efficiency of ACE2 for the generation of angiotensin (ANG)-1-7 from ANG II suggests an important role of ACE2 in preventing ANG II accumulation, while at the sa...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-008-0014-1

    authors: Wysocki J,González-Pacheco FR,Batlle D

    更新日期:2008-02-01 00:00:00